AIM V培养基CTSTM (治疗级别的)
- AIM V培养基CTSTM,是第一个商品化的,用于T细胞和树突细胞扩增的无血清培养基。
- AIM V培养基是目前唯一通过美国FDA 510(k)认证的,用于体外T细胞培养扩增的培养基。
- cGMP标准生产制造。
- 该培养基中包含:L-glutamine, 50 µg⁄ml streptomycin sulfate, and 10 µg⁄ml gentamicin sulfate
- 可以培养的细胞:PBMCs,Myeloma Cells,Macrophages,Hybridomas,Lymphocytes,Fibroblasts,T Cells,NK细胞,Monocytes,Dendritic Cells
国内使用该培养基的文献:
1、DC-CIK治疗缓解后急性白血病6例报告,刘清池等。
2、大量培养诱导乳腺癌患者自体 DC 和 CIK 细胞的研究,王先明等。
3、树突状细胞瘤苗的制备与临床应用进展,邹征云,刘宝瑞。
4、DC与CIK共培养对肝癌细胞杀伤活性的研究,陈宝安等。
5、CIK与DC细胞联合治疗145例晚期恶性实体瘤,应敏刚等。
无血清培养基对比图示:
参考文献:
1. Rebecca J et al., (2010) Natural exposure to cutaneous anthrax gives long lasting T cell immunity encompassing infection-specific Epitopes. J. Immunol., 184: 3814 – 3821
2. Fabricius D et al., (2010) Prostaglandin E2 inhibits IFN-α secretion and Th1 costimulation by human plasmacytoid dendritic cells via E-prostanoid 2 and E-prostanoid 4 receptor engagement. J. Immunol., 184: 677 – 684
3. Nesbit L et al., (2010) Polyfunctional T Lymphocytes Are in the Peripheral Blood of Donors Naturally Immune to Coccidioidomycosis and Are Not Induced by Dendritic Cells. Infect. Immun., 78: 309 - 315
4. Jahrsdorfer B et al., (2010) Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood, 115: 1156 – 1165
5. Csillag A et al., (2010) Pollen-Induced Oxidative Stress Influences Both Innate and Adaptive Immune Responses via Altering Dendritic Cell Functions. J. Immunol., 184: 2377 – 2385
6. Cornberg M et al., (2010) CD8 T Cell Cross-Reactivity Networks Mediate Heterologous Immunity in Human EBV and Murine Vaccinia Virus Infections. J. Immunol., 184: 2825 - 2838.
订购信息:
治疗级别的
产品名称 | 产品编号 | 包装规格 |
AIM V 液体培养基CTSTM(瓶装) | 0870112DK | 1000ml |
AIM V 液体培养基CTSTM(袋装) | 0870112BK | 10L |
科研级别的
产品名称 | 产品编号 | 包装规格 |
AIM V 液体培养基 | 12055091 | 500ml |
AIM V 液体培养基 | 12055083 | 1L |
AIM V 液体培养基(包含AlbuMAX BSA substituted for HSA) | 31035025 | 500ml |
更多产品详情请致电400-650-1950或浏览本公司网站www.siercheng.com